Serum and peritoneal exudate concentrations after high doses of β-lactams in critically ill patients with severe intra-abdominal infections - Université de Lorraine
Journal Articles Journal of Antimicrobial Chemotherapy Year : 2020

Serum and peritoneal exudate concentrations after high doses of β-lactams in critically ill patients with severe intra-abdominal infections

Abstract

Background: Critically ill patients with severe intra-abdominal infections (IAIs) requiring surgery may undergo several pharmacokinetic (PK) alterations that can lead to b-lactam underdosage. Objectives: To measure serum and peritoneal exudate concentrations of b-lactams after high doses and optimal administration schemes. Methods: This observational prospective study included critically ill patients with suspicion of IAI who required surgery and a b-lactam antibiotic as empirical therapy. Serum and peritoneal exudate concentrations were measured during surgery and after a 24h steady-state period. The PK/pharmacodynamic (PD) target was to obtain serum b-lactam concentrations of 100% fT>4%MIC based on a worst-case scenario (based on the EUCAST highest epidemiological cut-off values) before bacterial documentation (a priori) and redefined following determination of the MIC for the isolated bacteria (a posteriori). Registered with ClinicalTrials.gov (NCT03310606). Results: Forty-eight patients were included with a median (IQR) age of 64 (53–74) years and a SAPS II of 40 (32–65). The main diagnosis was secondary nosocomial peritonitis. Piperacillin/tazobactam was the most administered b-lactam antibiotic (75%). The serum/peritoneal piperacillin/tazobactam ratio was 0.88 (0.64–0.97) after a 24h steady-state period. Prior to bacterial documentation, 16 patients (33.3%) achieved the a priori PK/PD target. The identification of microorganisms was available for 34 patients (71%). Based on the MIC for isolated bacteria, 78% of the patients achieved the serum PK/PD target. Conclusions: In severe IAIs, high doses of b-lactams ensured 100% fT>4%MIC in the serum for 78% of critically ill patients with severe IAIs within the first 24h. In order to define optimal b-lactam dosing, the PK/PD target should take into account the tissue penetration and local ecology.
Fichier principal
Vignette du fichier
dkz407.pdf (194.46 Ko) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-02350602 , version 1 (10-02-2022)

Identifiers

Cite

Lisa Leon, Philippe Guerci, Elise Pape, Nathalie Thilly, Amandine Luc, et al.. Serum and peritoneal exudate concentrations after high doses of β-lactams in critically ill patients with severe intra-abdominal infections. Journal of Antimicrobial Chemotherapy, 2020, 75, pp.156-161. ⟨10.1093/jac/dkz407⟩. ⟨hal-02350602⟩
152 View
103 Download

Altmetric

Share

More